Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction.
Publication
, Journal Article
Tai, A; Ambrosy, AP; Fudim, M
Published in: Eur Heart J Cardiovasc Pharmacother
May 23, 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur Heart J Cardiovasc Pharmacother
DOI
EISSN
2055-6845
Publication Date
May 23, 2021
Volume
7
Issue
3
Start / End Page
e5 / e6
Location
England
Related Subject Headings
- Valsartan
- Stroke Volume
- Humans
- Heart Failure
- Biphenyl Compounds
- Aminobutyrates
- 3214 Pharmacology and pharmaceutical sciences
- 3201 Cardiovascular medicine and haematology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tai, A., Ambrosy, A. P., & Fudim, M. (2021). Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction. Eur Heart J Cardiovasc Pharmacother, 7(3), e5–e6. https://doi.org/10.1093/ehjcvp/pvab007
Tai, Andrew, Andrew P. Ambrosy, and Marat Fudim. “Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction.” Eur Heart J Cardiovasc Pharmacother 7, no. 3 (May 23, 2021): e5–6. https://doi.org/10.1093/ehjcvp/pvab007.
Tai A, Ambrosy AP, Fudim M. Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e5–6.
Tai, Andrew, et al. “Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction.” Eur Heart J Cardiovasc Pharmacother, vol. 7, no. 3, May 2021, pp. e5–6. Pubmed, doi:10.1093/ehjcvp/pvab007.
Tai A, Ambrosy AP, Fudim M. Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e5–e6.
Published In
Eur Heart J Cardiovasc Pharmacother
DOI
EISSN
2055-6845
Publication Date
May 23, 2021
Volume
7
Issue
3
Start / End Page
e5 / e6
Location
England
Related Subject Headings
- Valsartan
- Stroke Volume
- Humans
- Heart Failure
- Biphenyl Compounds
- Aminobutyrates
- 3214 Pharmacology and pharmaceutical sciences
- 3201 Cardiovascular medicine and haematology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1102 Cardiorespiratory Medicine and Haematology